GATA3 in T cell maturation/T helper cell differentiation
GATA3 in T cell maturation/T helper cell differentiation
批准号:
6607040
负责人:
SUNG-YUN PAI
金额:
$12.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2006-03-31
中文摘要
描述(申请人提供):GATA3,一种T细胞特异性转录
因子在免疫发育中起着两个核心作用。首先,它是必要的
对于T淋巴系的发展。其次,它引导着差异化
T辅助2型淋巴细胞(Th2细胞)并诱导Th2的产生
细胞因子,如IL-4、IL-5和IL-13。Th2细胞介导免疫反应
过敏、哮喘和寄生虫感染。因为破布-嵌合的GATA3-
基因缺陷的小鼠在T细胞发育的早期就受到了阻碍,几乎没有
已知GATA3在体内的功能。同样,GATA3通过的机制
诱导Th2细胞因子的产生尚不清楚。我们假设GATA3
在胸腺细胞发育、成熟T细胞迁移和
保持Th2表型;2)GATA3具有明显的结构
产生特定细胞因子所需的成分。我们
在目标1中建议产生一种在GATA3中条件缺陷的小鼠,例如
只有处于双阳性胸腺细胞阶段及以上的T细胞缺乏
GATA3和四环素响应型GATA3转基因小鼠。vbl.使用
条件性基因敲除和转基因模型我们将研究GATA3的作用
胸腺细胞发育中成熟T细胞的迁移和Th2的维持
表型。与其他GATA因素的替代可以让我们深入了解
定义GATA3功能的唯一和共享域。我们有初步的
数据,使用体外和体内的替代实验,不同的
GATA3的结构域是产生IL-4、IL-5和
IL-13。在目标2中,我们描述了这些数据将如何指导我们对
DNA结合、蛋白表达水平、GATA3乙酰化的作用
诱导其他Th2转录因子,以及尚未发现的合作伙伴
GATA3在Th2细胞因子产生机制中的作用。GATA3在中国的研究
体内和体外实验对Th2介导的治疗具有重要意义
疾病,如过敏、哮喘和对寄生虫感染的反应。
英文摘要
DESCRIPTION (provided by applicant): GATA3, a T cell-specific transcription
factor, plays two central roles in immune development. First, it is necessary
for the T lymphoid lineage development. Second, it directs the differentiation
of T helper type 2 lymphocytes (Th2 cells) and induces the production of Th2
cytokines, such as IL-4, IL-5 and IL-13. Th2 cells mediate the immune response
in allergy, asthma, and parasitic infection. Because RAG-chimeric GATA3-
deficient mice have an extremely early block in T cell development, little is
known about GATA3 function in vivo. Likewise, the mechanism by which GATA3
induces Th2 cytokine production remains unclear. We hypothesize that 1) GATA3
has essential functions in thymocyte development, mature T cell migration, and
maintenance of the Th2 phenotype; and 2) GATA3 has distinct structural
components that are required for the production of specific cytokines. We
propose in Aim 1 to generate a mouse conditionally deficient in GATA3, such
that only T cells at the double positive thymocyte stage and beyond lack
GATA3, and a tetracycline-responsive GATA3-expressing transgenic mouse. Using
the conditional knockout and transgenic models we will study the role of GATA3
in thymocyte development, mature T cell migration and maintenance of the Th2
phenotype. Substitution with other GATA factors can give us insight into the
unique and shared domains that define GATA3 function. We have preliminary
data, using substitution experiments in vitro and in vivo, that distinct
structural domains of GATA3 are necessary for the production of IL-4, IL-5 and
IL-13. In Aim 2, we describe how these data will guide our investigation of
the role of DNA binding, protein expression level, acetylation of GATA3,
induction of other Th2 transcription factors, and as yet undiscovered partners
of GATA3 in the mechanism of Th2 cytokine production. The study of GATA3 in
vivo and in vitro has important implications for the therapy of Th2-mediated
disease such as allergy, asthma, and the response to parasitic infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
-
批准号:10197472
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2017
-
负责人:SUNG-YUN PAI
-
依托单位:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
-
批准号:9755344
-
项目类别:
-
资助金额:$154.2万
-
财政年份:2017
-
负责人:SUNG-YUN PAI
-
依托单位:
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
-
批准号:9312746
-
项目类别:
-
资助金额:$59.84万
-
财政年份:2016
-
负责人:SUNG-YUN PAI
-
依托单位:
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
-
批准号:9143841
-
项目类别:
-
资助金额:$113.23万
-
财政年份:2016
-
负责人:SUNG-YUN PAI
-
依托单位:
Dose Finding Study of Busulfan for Newly Diagnosed Infants with SCID
-
批准号:8605312
-
项目类别:
-
资助金额:$25.82万
-
财政年份:2014
-
负责人:SUNG-YUN PAI
-
依托单位:
Humanized Mouse Models of Severe Combined Immunodeficiency
-
批准号:7806422
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2009
-
负责人:SUNG-YUN PAI
-
依托单位:
Advancing the Diagnosis and Treatment of Rare Primary Immune Disorders
-
批准号:10250420
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2009
-
负责人:SUNG-YUN PAI
-
依托单位:
Advancing the Diagnosis and Treatment of Rare Primary Immune Disorders
-
批准号:10018654
-
项目类别:
-
资助金额:$2.28万
-
财政年份:2009
-
负责人:SUNG-YUN PAI
-
依托单位:
Humanized Mouse Models of Severe Combined Immunodeficiency
-
批准号:7707949
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2009
-
负责人:SUNG-YUN PAI
-
依托单位:
GATA3 in T cell maturation/T helper cell differentiation
-
批准号:6602392
-
项目类别:
-
资助金额:$8.44万
-
财政年份:2002
-
负责人:SUNG-YUN PAI
-
依托单位:
GATA3 in T cell maturation/T helper cell differentiation
-
批准号:6725301
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2002
-
负责人:SUNG-YUN PAI
-
依托单位:
GATA3 in T cell maturation/T helper cell differentiation
-
批准号:6876706
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2002
-
负责人:SUNG-YUN PAI
-
依托单位:
GATA3 in T cell maturation/T helper cell differentiation
-
批准号:6417322
-
项目类别:
-
资助金额:$2.67万
-
财政年份:2002
-
负责人:SUNG-YUN PAI
-
依托单位:
Advancing the Diagnosis and Treatment of Rare Primary Immune Disorders
-
批准号:9804609
-
项目类别:
-
资助金额:$3.52万
-
财政年份:--
-
负责人:SUNG-YUN PAI
-
依托单位:
海外基金